A Phase II Trial for the Treatment of POEMS Syndrome With Daratumumab

POEMS syndrome

To Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During POEM Using GF 1500 UGI Scope A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis The Treatment of Lenalidomide in Patients With POEMS Syndrome A Phase II Trial for the Treatment of POEMS Syndrome With Daratumumab Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial POEMS Syndrome Treatment With Lenalidomide Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome